RESUMEN
O Estado de São Paulo registra neste segunda-feira (21) 33.984 óbitos e 937.332 casos confirmados do novo coronavírus. Entre o total de casos diagnosticados de COVID-19, 803.994 pessoas estão recuperadas, sendo que 103.141 foram internadas e tiveram alta hospitalar. As taxas de ocupação dos leitos de UTI são de 47% na Grande São Paulo e 47,7% no Estado. O número de pacientes internados é de 9.072, sendo 5.127 em enfermaria e 3.945 em unidades de terapia intensiva, conforme dados das 10h desta segunda. Hoje, os 645 municípios têm pelo menos uma pessoa infectada, sendo 562 com um ou mais óbitos. A relação de casos e óbitos confirmados por cidade pode ser consultada em: www.saopaulo.sp.gov.br/coronavirus. Entre as vítimas fatais estão 19.650 homens e 14.334 mulheres. Os óbitos continuam concentrados em pacientes com 60 anos ou mais, totalizando 76,2% das mortes. Observando faixas etárias, nota-se que a mortalidade é maior entre 70 e 79 anos (8.699), seguida pelas faixas de 60 a 69 anos (7.988) e 80 e 89 anos (6.920). Entre as demais faixas estão os: menores de 10 anos (40), 10 a 19 anos (63), 20 a 29 anos (281), 30 a 39 anos (966), 40 a 49 anos (2.245), 50 a 59 anos (4.493) e maiores de 90 anos (2.289). Os principais fatores de risco associados à mortalidade são cardiopatia (59,5% dos óbitos), diabetes mellitus (43,1%), doenças neurológicas (10,8%) e renal (9,6%), pneumopatia (8,3%). Outros fatores identificados são obesidade (7,7%), imunodepressão (5,6%), asma (3%), doenças hepáticas (2,1%) e hematológica (1,8%), Síndrome de Down (0,5%), puerpério (0,1%) e gestação (0,1%). Esses fatores de risco foram identificados em 27.284 pessoas que faleceram por COVID-19 (80,3%). Entre as pessoas que já tiveram confirmação para o novo coronavírus estão 437.225 homens e 494.016 mulheres. Não consta informação de sexo para 6.091 casos. A faixa etária que mais concentra casos é a de 30 a 39 anos (221.647), seguida pela faixa de 40 a 49 (194.841). As demais faixas são: menores de 10 anos (22.570), 10 a 19 (43.575), 20 a 29 (157.301), 50 a 59 (141.337), 60 a 69 (85.338), 70 a 79 (43.414), 80 a 89 (20.760) e maiores de 90 (6.053). Não consta faixa etária para outros 496 casos.
Asunto(s)
34658 , Comercio Electrónico , Aplicaciones Móviles/economía , Motocicletas/normas , Accidentes de Tránsito/prevención & control , Neumonía Viral/diagnóstico , Infecciones por Coronavirus/diagnóstico , Conservación de los Recursos Naturales , Incendios Forestales/prevención & control , Betacoronavirus/inmunología , Cuarentena/organización & administración , Sistemas Locales de Salud/organización & administración , Unidades de Cuidados Intensivos/estadística & datos numéricos , Capacidad de Camas en Hospitales/estadística & datos numéricos , Pandemias/estadística & datos numéricos , Pandemias/prevención & control , Infecciones por Coronavirus/epidemiología , Infecciones por Coronavirus/inmunología , Neumonía Viral/epidemiología , Neumonía Viral/inmunología , Vacunas Virales/provisión & distribución , Vacunas Virales/inmunología , Monitoreo Epidemiológico , Instituciones Académicas , Cobertura de Vacunación/provisión & distribución , Vacunas contra Poliovirus/provisión & distribuciónRESUMEN
BACKGROUND: Apps for real-time continuous glucose monitoring (CGM) on smartphones and other devices linked to CGM systems have recently been developed, and such CGM apps are also coming into use in Japan. In comparison with conventional retrospective CGM, the use of CGM apps improves patients' own blood glucose control, which is expected to help slow the progression of type 2 diabetes mellitus (DM) and prevent complications, but the effect of their introduction on medical costs remains unknown. OBJECTIVE: Our objective in this study was to perform an economic appraisal of CGM apps from the viewpoint of assessing public medical costs associated with type 2 DM, using the probability of developing type 2 DM-associated complications, and data on medical costs and utility value to carry out a medical cost simulation using a Markov model in order to ascertain the cost-effectiveness of the apps. METHODS: We developed a Markov model with the transition states of insulin therapy, nephrosis, dialysis, and cardiovascular disease, all of which have a major effect on medical costs, to identify changes in medical costs and utility values resulting from the introduction of a CGM app and calculated the incremental cost-effectiveness ratio (ICER). RESULTS: The ICER for CGM app use was US $33,039/quality-adjusted life year (QALY). CONCLUSIONS: Sensitivity analyses showed that, with the exception of conditions where the transition probability of insulin therapy, utility value, or increased medical costs increases, the ICER for the introduction of CGM apps was below the threshold of US $43,478/QALY used by the Central Social Insurance Medical Council. Our results provide basic data on the cost-effectiveness of introducing CGM apps, which are currently starting to come into use.
Asunto(s)
Automonitorización de la Glucosa Sanguínea/economía , Glucemia/metabolismo , Análisis Costo-Beneficio/métodos , Diabetes Mellitus Tipo 2/economía , Aplicaciones Móviles/economía , Automonitorización de la Glucosa Sanguínea/métodos , Diabetes Mellitus Tipo 2/sangre , Femenino , Humanos , Japón , Masculino , Cadenas de Markov , Años de Vida Ajustados por Calidad de Vida , Estudios RetrospectivosRESUMEN
mHealth, the use of mobile and wireless technologies in healthcare, and mHealth apps, a subgroup of mHealth, are expected to result in more person-focussed healthcare. These technologies are predicted to make patients more motivated in their own healthcare, reducing the need for intensive medical intervention. Thus, mHealth app technology might lead to a redesign of existing healthcare architecture making the system more efficient, sustainable, and less expensive. As a disruptive innovation, it might destabilise the existing healthcare organisation through a changed role for healthcare professionals with patients accessing care remotely or online. This account coincides with the broader narrative of National Health Service policy-makers, which focusses on personalised healthcare and greater patient responsibility with the potential for significant cost reductions. The article proposes that while the concept of mHealth apps as a disruptive technology and the narrative of personalisation and responsibilisation might support a transformation of the healthcare system and a reduction of costs, both are dependent on patient trust in the safety and security of the new technology. Forcing trust in this field may only be achieved with the application of traditional and other regulatory mechanisms and with this comes the risk of reducing the effect of the technology's disruptive potential.
Asunto(s)
Tecnología Disruptiva/legislación & jurisprudencia , Aplicaciones Móviles/legislación & jurisprudencia , Telemedicina/legislación & jurisprudencia , Confianza , Seguridad Computacional/legislación & jurisprudencia , Tecnología Disruptiva/economía , Tecnología Disruptiva/tendencias , Regulación Gubernamental , Aplicaciones Móviles/economía , Aplicaciones Móviles/tendencias , Programas Nacionales de Salud , Formulación de Políticas , Seguridad , Telemedicina/economía , Telemedicina/tendencias , Reino UnidoAsunto(s)
Contratos , Fertilidad , Consentimiento Informado , Menstruación , Aplicaciones Móviles/economía , Aplicaciones Móviles/ética , Aplicaciones Móviles/legislación & jurisprudencia , Confidencialidad , Exactitud de los Datos , Femenino , Regulación Gubernamental , Humanos , Difusión de la InformaciónRESUMEN
BACKGROUND: Suicide constitutes a cause of death which could be prevented by e-health programs accessible to the general population. Effective promotion has the potential to maximize the uptake of such programs. However, few e-health programs have been combined with promotion campaigns. The primary objective of this trial is to assess the effectiveness of a tailored promotion, at a local level, of a mobile application and website offering evidence-based content for suicide prevention (the StopBlues program), and to compare the effectiveness of two types of local promotion in terms of their impact on suicidal acts. Secondary objectives focus on the effectiveness of the promotion in terms of the intensity of utilization of the StopBlues program, help-seeking behaviors and the level of psychological impairment of program users. METHODS/DESIGN: This is a three-arm, parallel-group, cluster-randomized controlled trial, with before-and-after observation. Thirty-four clusters, corresponding to geographical areas sharing a common local authority in France, will be included. They will be randomly assigned to one of the following arms with a ratio of 1:1:1: a control group; a basic promotion group in which promotion of the StopBlues program will be done by local authorities; and an intensified promotion group in which basic promotion will be supplemented by an additional one in a general practitioner's waiting room. The primary outcome measure will be the number of suicidal acts within each cluster over a 12-month period following the launch of the intervention. Baseline data will be collected for each cluster over the 12-month period prior to the trial. Secondary outcomes will include length of use of the StopBlues program, measures of help-seeking behaviors and level of psychological distress among users of the program, as well as the cost-effectiveness and budgetary impact of its promotion. A more sustained promotion by local authorities will also be implemented after 12 months in the control group and assessed using the same outcome measures. DISCUSSION: This research should contribute to the sparse evidence base regarding the promotion of e-health programs and will support the wider delivery of the intervention evaluated if proven effective. TRIAL REGISTRATION: ClinicalTrials.gov, ID: NCT03565562. Registered on 11 June 2018.
Asunto(s)
Promoción de la Salud/métodos , Aplicaciones Móviles , Teléfono Inteligente , Prevención del Suicidio , Telemedicina/métodos , Adulto , Análisis por Conglomerados , Análisis Costo-Beneficio , Femenino , Estudios de Seguimiento , Francia , Promoción de la Salud/economía , Humanos , Masculino , Salud Mental , Aplicaciones Móviles/economía , Evaluación de Programas y Proyectos de Salud , Distrés Psicológico , Ensayos Clínicos Controlados Aleatorios como Asunto , Suicidio/psicología , Telemedicina/economíaRESUMEN
BACKGROUND AND OBJECTIVES: Although gaming disorder is increasingly recognized, there has been limited consideration of the impact of free-to-play games with in-game purchases, also called microtransactions. METHODS: Case report (n = 1). RESULTS: A patient with posttraumatic stress disorder, major depressive disorder in remission, polysubstance use disorders in remission, and opioid use disorder on buprenorphine/naloxone developed gaming disorder (based on International Classification of Diseases, 11th revision) and spent up to 40% of his monthly income on microtransactions within a smartphone game. Treatment consisted of relinquishing access to electronic payment mechanisms, motivational interviewing, and couples therapy. DISCUSSION AND CONCLUSIONS: The case highlights how in-game purchases may cause patients with gaming disorder to experience financial consequences, and the need for further characterization of the clinical ramifications of microtransactions. SCIENTIFIC SIGNIFICANCE: To the best of our knowledge, this is the first report in the medical literature of a patient with gaming disorder developing excessive in-game spending from expenditures on microtransactions. (Am J Addict 2020;29:528-530).
Asunto(s)
Conducta Adictiva/economía , Conducta Adictiva/psicología , Aplicaciones Móviles/economía , Teléfono Inteligente , Trastornos por Estrés Postraumático/psicología , Juegos de Video/economía , Juegos de Video/psicología , Conducta Adictiva/terapia , Humanos , Masculino , Persona de Mediana Edad , Trastornos por Estrés Postraumático/complicaciones , Trastornos por Estrés Postraumático/economía , Trastornos por Estrés Postraumático/terapia , Estados Unidos , Salud de los VeteranosRESUMEN
The Federal Trade Commission (FTC) has an important role to play in the governmental oversight of mobile health apps, ensuring consumer protections from unfair and deceptive trade practices and curtailing anti-competitive methods. The FTC's consumer protection structure and authority is outlined before reviewing the recent FTC enforcement activities taken on behalf of consumers and against developers of mhealth apps. The article concludes with identification of some challenges for the FTC and modest recommendations for strengthening the consumer protections it provides.
Asunto(s)
Aplicaciones Móviles/legislación & jurisprudencia , Telemedicina/legislación & jurisprudencia , United States Federal Trade Commission , Comercio , Decepción , Competencia Económica , Humanos , Aplicaciones Móviles/economía , Telemedicina/economía , Estados UnidosRESUMEN
BACKGROUND: Incurable cancer does not only affect patients, it also affects the lives of their partners. Many partners take on caregiving responsibilities. The burden of these caregiving tasks are often associated with physical, psychological, and social difficulties and many partners have unmet supportive care needs. Oncokompas is an eHealth self-management application to support partners in finding and obtaining optimal supportive care, tailored to their quality of life and personal preferences. A randomized controlled trial will be carried out to determine the efficacy and cost-utility of Oncokompas. METHODS: A total of 136 adult partners of patients with incurable cancer will be included. Partners will be randomly assigned to the intervention group, which directly gets access to Oncokompas, or the waiting-list control group, which gets access to Oncokompas after three months. The primary outcome measure is caregiver burden. Secondary outcome measures comprise self-efficacy, health-related quality of life, and costs. Measures will be assessed at baseline, two weeks after randomization, and three months after the baseline measurement. DISCUSSION: This study will result in evidence on the efficacy and cost-utility of Oncokompas among partners of patients with incurable cancer, which might lead to implementation of Oncokompas as a health service for partners of patients with incurable cancer. TRIAL REGISTRATION: Netherlands Trial Register, NTR 7636. Registered on 23 November 2018.
Asunto(s)
Cuidadores , Aplicaciones Móviles , Sistemas de Apoyo Psicosocial , Automanejo , Esposos , Telemedicina , Adaptación Psicológica , Adulto , Cuidadores/educación , Cuidadores/psicología , Análisis Costo-Beneficio , Educación a Distancia/métodos , Femenino , Humanos , Masculino , Aplicaciones Móviles/economía , Aplicaciones Móviles/normas , Neoplasias/psicología , Utilización de Procedimientos y Técnicas , Ensayos Clínicos Controlados Aleatorios como Asunto , Automanejo/educación , Automanejo/métodos , Automanejo/psicología , Esposos/educación , Esposos/psicología , Telemedicina/economía , Telemedicina/métodosRESUMEN
The evolution of technology makes it likely that a large number of people will invest in and use health-related mobile applications and wearable devices. Yet the question remains: Do these technology-based interventions modify health behavior and improve health and are we getting our money's worth? The vast majority of studies concerning health-related apps and wearable devices have small sample sizes and short time spans of 6 months or less, so it is not clear if these durations were determined by lack of consistent use over time. Furthermore, many of the most popular applications have not been subjected to randomized trials. Overall, the small demonstrated improvements in outcomes are often associated with professional involvement from clinicians, coaches, or diabetes educators provided in conjunction with use of mobile health (mHealth) platforms. This paper explores the use of mHealth technologies that address cardiovascular disease/prevention (eg, diabetes, diet, physical activity, and associated weight loss) and discusses the lack of adequate evidence to support even minimal patient investment in mobile applications or wearable devices at this time.
Asunto(s)
Enfermedades Cardiovasculares/prevención & control , Costos de la Atención en Salud , Aplicaciones Móviles/economía , Aceptación de la Atención de Salud , Servicios Preventivos de Salud/economía , Telemedicina/economía , Dispositivos Electrónicos Vestibles/economía , Enfermedades Cardiovasculares/diagnóstico , Enfermedades Cardiovasculares/epidemiología , Análisis Costo-Beneficio , Conductas Relacionadas con la Salud , Conocimientos, Actitudes y Práctica en Salud , Estilo de Vida Saludable , Humanos , Conducta de Reducción del Riesgo , Autocuidado/economía , Telemedicina/instrumentaciónRESUMEN
Recent studies have focused on the use of technology to support reminiscence but there remains a dearth of research on the health costs and benefits associated with this intervention. The aim of this study was to estimate costs and quality of life associated with a home based, individual specific reminiscence intervention, facilitated by an iPad app for people living with dementia and their family carers, with a view to informing a future cost-effectiveness analysis. Use of community health and social care services, hospital services, prescribed medication and informal caregiving was assessed using an adapted version of the Client and Socio-Demographic Service Receipt Inventory (CSRI) at baseline and 3-month follow-up. Quality of life was assessed at baseline, 6-week and 3-month follow-up using the EQ5D, DEMQOL and DEMQOL proxy instruments. Results showed that average health and social care costs were £29,728 per person at baseline (T0) and £33,436 after 3 months (T2). Higher T2 costs were largely accounted for by higher informal caregiving costs. There was an overall increase in health-related quality of life over the duration of the intervention, although there were notable differences in index scores generated by the EQ5D (0.649, 0.652 and 0.719) and DEMQOL instruments (0.845, 0.968 and 0.901). The study concluded that a full cost-effectiveness analysis could incorporate a similar range of cost-categories with minor amendments to the CSRI to improve the accuracy of cost estimation. Furthermore, a larger sample size, randomisation and longer follow-up period are required to allow potential effects of the intervention to be realised and differences between intervention and control groups to be accurately detected.
Asunto(s)
Demencia , Memoria , Aplicaciones Móviles/economía , Calidad de Vida , Cuidadores , Análisis Costo-Beneficio , Estudios de Factibilidad , HumanosRESUMEN
Self-management schemes and mobile apps can be used for the management of hypertension in the community, but the most appropriate patient population is unknown. To explore whether the Chinese Health Literacy Scale (CHLSH) can be used to screen for appropriate patients with hypertension for self-management and to evaluate the clinical effectiveness and health economic evaluation of three hypertension management schemes. This was a prospective study performed from March 2017 to July 2017 in consecutive patients with primary hypertension and of 50-80 years of age from the Jinyang community, Wuhou District, Chengdu. The CHLSH was completed and the patients were classified into the high (n = 283) and low (n = 315) health literacy groups. The patients were randomly divided into the self-management, traditional management, and mobile app management groups. The high-health literacy group was selected to construct the cost-effectiveness decision tree model. Blood pressure control rate and the quality-adjusted life years (QALYs) were determined. At the end of follow-up, the success rate of self-management was 83.4%. The costs for 6 months of treatment for each patient with hypertension in the self-management, traditional management, and mobile app groups were 1266, 1751, and 1856 yuan, respectively. The costs required for obtaining 1 QALY when managing for 6 months were: 30,869 yuan for self-management; 48,628 yuan for traditional management; and 43,199 yuan for the mobile app. The CHLSH can be used as a tool for screening patients with hypertension for self-management. The cost-effectiveness of self-management was optimal.
Asunto(s)
Redes Comunitarias/economía , Hipertensión/terapia , Anciano , Análisis de Varianza , China/epidemiología , Redes Comunitarias/tendencias , Análisis Costo-Beneficio/métodos , Femenino , Humanos , Hipertensión/economía , Hipertensión/epidemiología , Masculino , Persona de Mediana Edad , Aplicaciones Móviles/economía , Aplicaciones Móviles/tendencias , Estudios Prospectivos , Psicometría/instrumentación , Psicometría/métodos , Años de Vida Ajustados por Calidad de Vida , Automanejo/economía , Automanejo/métodosRESUMEN
La pandemia de COVID-19 ha puesto de manifiesto la importancia de las tecnologías digitales y, en particular, de la conectividad para el bienestar social y económico de las personas. Con las medidas de aislamiento impuestas para frenar la propagación de la pandemia, muchas actividades de la vida diaria (incluidos el trabajo, el aprendizaje, las compras y las reuniones sociales) tomaron una forma digital, lo que ha permitido que amigos y familias distanciados se mantengan informados y conectados, y que la actividad económica continúe. La conectividad digital también brindó una plataforma para la innovación, que habilitó nuevas maneras de prestar servicios esenciales de manera remota, incluidas la educación y la atención a la salud
Asunto(s)
Humanos , Telemedicina , Aplicaciones Móviles/economía , Tecnología Digital/tendencias , COVID-19 , Política Pública/tendencias , América LatinaRESUMEN
PURPOSE: To determine whether a white-eye detector smartphone application (app) can be used as a screening tool to detect early signs of leukocoria in a clinical practice. METHODS: A prospective, single-visit study of children aged 1 to 6 years presenting to the University Eye Clinic of Genova for a complete pediatric ophthalmologic examination was conducted. All children who met the enrollment criteria were screened by an orthoptist with the CRADLE (Computer Assisted Detector of Leukocoria) smartphone app for an iPhone operating system (iOS) (iPhone 7; Apple, Cupertino, CA). Cycloplegic retinoscopy and fundus examination were performed 30 minutes after one to two drops of a pediatric combination drop, comprising tropicamide 1% and phenylephrine 2.5%, were instilled. A comparison between the two methods yielded sensitivity, specificity, and negative likelihood ratio values. RESULTS: A total of 244 eyes of 122 children were included in the study. Nine eyes of 244 (3.6%) had leukocoria evaluable by penlight caused by amblyogenic cataract, 1 (0.4%) patient had retinopathy of prematurity stage 5, and 3 (1.2%) patients had retinoblastoma. The sensitivity of the white-eye detector app was 15.38% (95% confidence interval [CI]: 1.92% to 45.45%), the specificity was 100% (95% CI: 98.48% to 100.00%), and the negative likelihood ratio was 0.85 (95% CI: 0.67 to 1.07). CONCLUSIONS: A smartphone photoscreening app able to detect leukocoria may provide valuable support for children's parents. However, it cannot be considered an alternative to the ophthalmoscope for children. [J Pediatr Ophthalmol Strabismus. 2019;56(4):229-232.].
Asunto(s)
Enfermedades del Iris/diagnóstico , Aplicaciones Móviles/provisión & distribución , Reflejo Pupilar/fisiología , Teléfono Inteligente , Selección Visual/métodos , Niño , Preescolar , Femenino , Humanos , Lactante , Enfermedades del Iris/fisiopatología , Masculino , Aplicaciones Móviles/economía , Estudios Prospectivos , Reproducibilidad de los Resultados , Factores de RiesgoAsunto(s)
Países en Desarrollo , Equipos y Suministros/provisión & distribución , Solución de Problemas , Proyectos de Investigación , Investigadores , Investigación/organización & administración , Tecnología/organización & administración , Teléfono Celular/economía , Teléfono Celular/provisión & distribución , Computadores/economía , Computadores/provisión & distribución , Países en Desarrollo/economía , Suministros de Energía Eléctrica , Equipos y Suministros/economía , Internet , Aplicaciones Móviles/economía , Publicación de Acceso Abierto , Investigación/economía , Investigadores/economía , Investigadores/psicología , Red Social , Programas Informáticos/economía , Programas Informáticos/provisión & distribución , Tecnología/economía , Tecnología/instrumentaciónRESUMEN
We report a generic smartphone app for quantitative annotation of complex images. The app is simple enough to be used by children, and annotation tasks are distributed across app users, contributing to efficient annotation. We demonstrate its flexibility and speed by annotating >30,000 images, including features of rice root growth and structure, stem cell aggregate morphology, and complex worm (Caenorhabditis elegans) postures, for which we show that the speed of annotation is >130-fold faster than state-of-the-art techniques with similar accuracy.
Asunto(s)
Caenorhabditis elegans/fisiología , Procesamiento de Imagen Asistido por Computador/métodos , Aplicaciones Móviles , Animales , Caenorhabditis elegans/anatomía & histología , Humanos , Procesamiento de Imagen Asistido por Computador/economía , Aplicaciones Móviles/economía , Movimiento , Teléfono Inteligente , Factores de TiempoRESUMEN
BACKGROUND: Caring for individuals with chronic conditions is labor intensive, requiring ongoing appointments, treatments, and support. The growing number of individuals with chronic conditions makes this support model unsustainably burdensome on health care systems globally. Mobile health technologies are increasingly being used throughout health care to facilitate communication, track disease, and provide educational support to patients. Such technologies show promise, yet they are not being used to their full extent within US health care systems. OBJECTIVE: The purpose of this study was to examine the use of staff and costs of a remote monitoring care model in persons with and without a chronic condition. METHODS: At Dartmouth-Hitchcock Health, 2894 employees volunteered to monitor their health, transmit data for analysis, and communicate digitally with a care team. Volunteers received Bluetooth-connected consumer-grade devices that were paired to a mobile phone app that facilitated digital communication with nursing and health behavior change staff. Health data were collected and automatically analyzed, and behavioral support communications were generated based on those analyses. Care support staff were automatically alerted according to purpose-developed algorithms. In a subgroup of participants and matched controls, we used difference-in-difference techniques to examine changes in per capita expenditures. RESULTS: Participants averaged 41 years of age; 72.70% (2104/2894) were female and 12.99% (376/2894) had at least one chronic condition. On average each month, participants submitted 23 vital sign measurements, engaged in 1.96 conversations, and received 0.25 automated messages. Persons with chronic conditions accounted for 39.74% (8587/21,607) of all staff conversations, with higher per capita conversation rates for all shifts compared to those without chronic conditions (P<.001). Additionally, persons with chronic conditions engaged nursing staff more than those without chronic conditions (1.40 and 0.19 per capita conversations, respectively, P<.001). When compared to the same period in the prior year, per capita health care expenditures for persons with chronic conditions dropped by 15% (P=.06) more than did those for matched controls. CONCLUSIONS: The technology-based chronic condition management care model was frequently used and demonstrated potential for cost savings among participants with chronic conditions. While further studies are necessary, this model appears to be a promising solution to efficiently provide patients with personalized care, when and where they need it.
Asunto(s)
Enfermedad Crónica/terapia , Aplicaciones Móviles/normas , Atención Dirigida al Paciente/métodos , Adulto , Anciano , Enfermedad Crónica/economía , Enfermedad Crónica/psicología , Estudios de Cohortes , Manejo de la Enfermedad , Femenino , Humanos , Masculino , Persona de Mediana Edad , Aplicaciones Móviles/economía , Aplicaciones Móviles/tendencias , Atención Dirigida al Paciente/normas , Proyectos Piloto , Autocuidado/métodosRESUMEN
BACKGROUND: The prevalence of diabetes has increased substantially in Mexico over the last 40 years, leading to significant impacts on population health and the healthcare system. Technology-based solutions may improve diabetes outcomes in areas where lack of efficient transportation creates barriers to care. OBJECTIVES: To estimate the lifetime cost-effectiveness of a technology-based diabetes care management program from the perspective of the Mexican healthcare system. METHODS: Clinical outcomes and cost data from a 3-arm randomized clinical trial of Dulce Wireless Tijuana, a diabetes care management program incorporating short-term mobile technology, were used as inputs in a validated simulation model for type 2 diabetes. Study arms included a control group (CG), Project Dulce diabetes care management (PD), and Project Dulce with technology enhancement (PD-TE). RESULTS: Intervention costs were $1448 for PD and $1740 for PD-TE compared with $740 for CG. Both intervention arms increased quality-adjusted life-years and costs. The incremental cost-effectiveness ratio for PD was $1635 and for PD-TE was $2220, both compared with CG. The incremental cost-effectiveness ratio for PD-TE versus PD was $4299. The results were sensitive to the time horizon. The PE and PD-TE interventions were cost-effective under time horizons of 15 to 20 years, but were not cost-effective under time horizons of 5 to 10 years. CONCLUSIONS: Both the PD and PD-TE were highly cost-effective from a Mexican health system perspective. Considering the economic impact of the diabetes epidemic and the widespread use of cellular technology in Mexico, implementation of PD-TE is warranted.
Asunto(s)
Diabetes Mellitus Tipo 2/terapia , Telemedicina , Tecnología Biomédica/economía , Tecnología Biomédica/métodos , Análisis Costo-Beneficio , Diabetes Mellitus Tipo 2/economía , Femenino , Costos de la Atención en Salud , Humanos , Masculino , México , Persona de Mediana Edad , Aplicaciones Móviles/economía , Años de Vida Ajustados por Calidad de Vida , Telemedicina/economía , Telemedicina/métodos , Resultado del TratamientoRESUMEN
BACKGROUND: Information and communications technologies are transforming our social interactions and life-styles. One of the most promising applications of information technology is healthcare and wellness management that characterized by early detection of conditions, prevention, and long-term healthcare management. OBJECTIVE: The main purpose of this document is to do a study, first about the actual literature about mobile phone applications to measure and control heart-rate and second a study about these applications themselves, analyzing the different app stores more popular nowadays, Google Play Store and iTunes (for Android and iOS devices respectively). METHODS: The Web portals and databases that were used to perform the searches are IEEE Xplore, National Center for Biotechnology Information, Springer, ResearchGate, Science Direct and Scopus, taking into account the date of publication from 2010 to 2018, publications in English and Spanish. RESULTS: 40 relevant papers have been found related to mobile phone apps to measure and control heart rate. The results show that of a total of 400 applications found 61.25% of them are in the Play Store (Android systems) and the remaining 38.75% were found in the iTunes Store (iOS systems). CONCLUSIONS: From the review of the research articles analyzed, it can be said that the most applications found are for Android devices. They occupy 76.53% of the world mobile phone market, while iOS only owns 18.97%.